Fomentamos la colaboración
para la transformación digital
y la sostenibilidad.

Creamos un espacio de encuentro y colaboración entre empresas y entidades para el desarrollo de soluciones innovadoras que mejoren su competitividad en cualquier sector.

Transformación con propósito.

Sign in/up

¡Bienvenido a la Plataforma de Open Innovation del ecosistema Secartys!

Busca una
oportunidad

¿Quieres ser parte de un proyecto? Busca una oportunidad y aporta tu solución.

Express interest
Repair of tissue and organ damage in refractory chronic graf...
created · Updated
Deadline: Dec 31, 2021
Received 0 expressions of interest

Summary

Our proposal encompasses parallel clinical trials addressing the feasibility and the effectiveness of donor-derived regulatory T cells (Treg) as a therapeutic agent in the treatment and prevention of tissue and organ damage resulting from graft versus host disease (GVHD) after...

Description

Our proposal encompasses parallel clinical trials addressing the feasibility and the effectiveness of donor-derived regulatory T cells (Treg) as a therapeutic agent in the treatment and prevention of tissue and organ damage resulting from graft versus host disease (GVHD) after hematopoietic stem cell transplantation (HSCT).<br/>We propose a collaborative clinical study in which Treg therapy for GHVD is the common dominator. However, by bringing together several clinical centers with expertise in this area, we are also having the opportunity to simultaneously address other issues that would not otherwise be addressable by each clinical center on its own. Firstly, by using different Treg preparation strategies, we will be able to determine whether ex vivo isolated Treg are sufficient or whether in vitro expansion and subsequently higher dosages are required. Secondly, we will investigate if sole Treg infusion is effective or if rather co-administration of therapeutic agents that are likely to induce Treg survival and expansion in vivo (rapamycin; IL-2) is required for a successful response to Treg therapy.<br/>The studies on GVHD treatment outcome will be pursued together with a detailed analysis of immune monitoring, comprising T cell receptor clonotype tracking and tissue regeneration markers, in order to further understand the mechanisms underlying the therapeutic and regenerative potential of Treg cells. <br/>Our consortium has developed a concerted approach to the topic of Treg therapy in GVHD. This is a unique opportunity to determine the validity of this cellular immunotherapy approach in GVHD prevention and treatment, with potential for a significant impact on patient quality of life, survival rate and ultimately on the quality of health care provided.

Crea una
oportunidad

Publica tu proyecto, idea, reto o necesidad y genera el interés de potenciales colaboradores o proveedores.

Latest Opportunities
Desde TTA, socia del proyecto Erasmus+ AgriFood4Future, te invitamos a unirte al CoVE España: una red de empresas, centros de formación, universidades y profesionales del sector agroalimentario que impulsa nuevas competencias y colaboración en agricultura inteligente y sistemas alimentarios sostenibles. Adhesión sencilla y sin compromiso: https://agrifood4future.com/ecosystem/coves/ Para mas información del proyecto visita https://agrifood4future.com/

Únete y crea
tu ecosistema

Conoce, conecta e interactúa con expertos de todo el ecosistema Secartys gracias a las diferentes funcionalidades de Secartys INNOVA.

Podrás crear espacios privados, generar listas de oportunidades, publicar tus proyectos, conocer las propuestas de otros y activar alertas en función de tus intereses.

¡Crea tu perfil y da paso a la innovación!

Fomentamos la colaboración para la transformación digital y la sostenibilidad.

¡ÚNETE AHORA!